The natural immune protection that develops after a SARS-CoV-2 infection offers considerably more of a shield against the Delta variant of the pandemic coronavirus than two doses of the Pfizer-BioNTech vaccine, according to a large Israeli study that some scientists wish came with a “Don’t try this at home” label. The newly released data show people who once had a SARS-CoV-2 infection were much less likely than vaccinated people to get Delta, develop symptoms from it, or become hospitalized with serious COVID-19.

READ FULL ARTICLE AT SCIENCE MAG.COM

Other Headlines

Health & Nutrition

DISASTER: Hospital waiting lists hit six million in England

The number of people on a hospital waiting list in England has hit six million for the first time. And about one in 20 of those has been waiting – for routine care such as knee and hip surgery – for more than a year. The figures are for the end of November – beforeContinue reading DISASTER: Hospital waiting lists hit six million in England

More news about Health & Nutrition